Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Resch

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Life (Basel, Switzerland)|April 23, 2022
How to Provide Breast Milk for the Preterm Infant and Avoid Symptomatic Cytomegalovirus Infection with Possible Long-Term SequelaeBernhard Resch
World Journal of Clinical Pediatrics|September 26, 2014
Burden of respiratory syncytial virus infection in young childrenBernhard Resch
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infantsBernhard Resch
The Open Microbiology Journal|August 19, 2014
Respiratory Syncytial Virus Infection in High-risk Infants - an Update on Palivizumab ProphylaxisBernhard Resch
Human Vaccines & Immunotherapeutics|June 13, 2017
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infectionBernhard Resch
Frontiers in Pediatrics|April 11, 2022
Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis: Systematic ReviewJulia Eichberger, Bernhard Resch
Early Human Development|February 1, 2011
Are late preterm infants as susceptible to RSV infection as full term infants?Bernhard Resch, Bosco Paes
Human Relations; Studies Towards the Integration of the Social Sciences|December 26, 2024
Addressing durability in collaborative organising: Event atmospheres and polyrhythmic affectivityBernhard Resch, David Rozas
Current Opinion in Cardiology|January 23, 2013
Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumabBernhard Resch, Ina Michel-Behnke
Clinical Chemistry and Laboratory Medicine|December 4, 2010
Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of lifeNora Hofer, Wilhelm Müller, Bernhard Resch
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Life (Basel, Switzerland)|April 23, 2022
How to Provide Breast Milk for the Preterm Infant and Avoid Symptomatic Cytomegalovirus Infection with Possible Long-Term SequelaeBernhard Resch
World Journal of Clinical Pediatrics|September 26, 2014
Burden of respiratory syncytial virus infection in young childrenBernhard Resch
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infantsBernhard Resch
The Open Microbiology Journal|August 19, 2014
Respiratory Syncytial Virus Infection in High-risk Infants - an Update on Palivizumab ProphylaxisBernhard Resch
Human Vaccines & Immunotherapeutics|June 13, 2017
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infectionBernhard Resch
Frontiers in Pediatrics|April 11, 2022
Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis: Systematic ReviewJulia Eichberger, Bernhard Resch
Early Human Development|February 1, 2011
Are late preterm infants as susceptible to RSV infection as full term infants?Bernhard Resch, Bosco Paes
Human Relations; Studies Towards the Integration of the Social Sciences|December 26, 2024
Addressing durability in collaborative organising: Event atmospheres and polyrhythmic affectivityBernhard Resch, David Rozas
Current Opinion in Cardiology|January 23, 2013
Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumabBernhard Resch, Ina Michel-Behnke
Clinical Chemistry and Laboratory Medicine|December 4, 2010
Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of lifeNora Hofer, Wilhelm Müller, Bernhard Resch
Pageof 9